Uterine excitation-contraction and tocolytics

Vivian Imbriotis | July 22, 2026

Stimulus for contraction

  • Oxytocin
  • High oestrogen:progesterone ratio
  • Prostaglandins
  • Mechanical stretch of uterus/cervix

Uterine smooth muscle modifications

  • Numerous gap junctions \(\to\) forms functional syncytium
  • Unstable membrane potential \(\to\) spontaneous depolarizations
  • Exhibits baseline tone

Steps of contraction

  • Depolarization opens L-type calcium channels \(\to\) calcium influx
  • Calcium binds to calmodulin and MLCK \(\to\) phosphorylates light chain of myosin
  • Myosin-actin cross-bridge cycling occurs, consuming ATP \(\to\) contraction

Tocolytics (class, dose, MOA, AEs)

Salbutamol

  • Beta-2 agonist (some beta-1 activity)
  • 10mcg/min infusion
  • \(\uparrow\)cAMP \(\to\) \(\uparrow\)PKA \(\to \ \uparrow\)phosphorylation (inactivation) of MLCK \(\to\) relaxation
  • Causes maternal + foetal tachycardia. Maternal hypokalaemia, lactic acidosis, hyperglycaemia

Magnesium

  • Divalent cation
  • 16mmol load \(\to\) 8mmol/hr IV
  • Blocks L-type calcium channels \(\to\) lower intracellular Ca \(\to\) less Ca-calmodulin-MLCK complex activity
  • Causes hypotension, maternal AV blocks \(\to\) cardiac arrest, muscle weakness \(\to\) resp arrest, sedation

Nifedipine

  • Dihydropyridine CCB
  • 20mg PO \(to\) 20mg QID
  • Blocks L-type calcium channels \(\to\) lower intracellular Ca \(\to\) less Ca-calmodulin-MLCK complex activity
  • Causes headache, flushing, dizziness, hypotension. Impairs HPV \(\to\) maternal V/Q mismatch.